0001628280-24-004486.txt : 20240213
0001628280-24-004486.hdr.sgml : 20240213
20240213163735
ACCESSION NUMBER: 0001628280-24-004486
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waters Kevin
CENTRAL INDEX KEY: 0001653771
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 24626734
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 6502329832
MAIL ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
wk-form4_1707860221.xml
FORM 4
X0508
4
2024-02-12
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001653771
Waters Kevin
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CFO
1
Common Stock
2024-02-12
4
M
0
22349
4.52
A
55872
D
Common Stock
2024-02-12
4
S
0
22349
50.1616
D
33523
D
Stock Option (Right to Buy)
4.52
2024-02-12
4
M
0
22349
0
D
2028-10-22
Common Stock
22349
51927
D
All transactions reported were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock Option was granted on October 23, 2018 and vested over a four year period.
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
2024-02-12